The use of prostaglandin-E1 immediately after birth and subsequent surgical creation of the modified Blalock-Taussig shunt (BTS) shunt have remarkably improved the prognosis and survival of children with congenital heart disease and ductal-dependent pulmonary blood flow (PBF). Despite the advancement in surgical techniques, bypass strategies, and postoperative management, significant morbidity and mortality after BTS still remain. Patent ductus arteriosus stenting has been shown to be as an acceptable alternative to BTS placement in select infants with ductal-dependent PBF. Newer procedural techniques and equipment, along with operator experience have all contributed to procedural refinement associated with improved outcomes over the recent years. In this article, we review the procedural and periprocedural details, with an emphasis on recent advances of this procedure.
| INTRODUC TI ON
Despite being first performed in 1944, and subsequently refined over the ensuing decades, the modified Blalock-Taussig shunt (BTS) procedure remains an operation with significant mortality and morbidity even in the current area. In a large multicenter report from
The Society of Thoracic Surgeons Congenital Heart Surgery (STS-CHS) Database, a cohort of neonates who underwent modified BTS placement without concomitant procedures experienced in-hospital mortality at a rate of 7.2%. 1 Using an audit dataset from the United Kingdom to capture a large cohort of patients who had surgery for placement of an isolated BTS, Dorobantu et al reported an overall mortality rate of 13.9% and a 17.8% risk of BTS reintervention. 2 Considering the high mortality and morbidity associated with a BTS, alternative less invasive approaches to maintaining ductal patency (eg, stenting of the PDA) have been explored.
Stenting of the PDA for ductal-dependent pulmonary blood flow (PBF) can be a technically challenging procedure. The first reports of PDA stenting for ductal-dependent PBF infants were published in 1992 by Gibbs et al. 3 In their initial experience, the operators faced a number of technical barriers. The stents that were initially used for this procedure were hand crimped on balloons, thus necessitating the use of relatively bulky delivery systems and sheaths. Since then, a number of innovations in techniques, equipment, and subsequent experience of operators have all played a vital role in how the procedure has evolved over the recent years. [4] [5] [6] [7] [8] [9] [10] [11] In fact, in the current era, PDA stenting for ductal-dependent PBF has been found to be an acceptable alternative to surgical BTS in select patients. In two relatively large multicenter studies, one reported from our group 
S P E C I A L I S S U E A R T I C L E
Stenting of the ductus arteriosus for ductal-dependent pulmonary blood flow-current techniques and procedural considerations and one from the United Kingdom, PDA stenting was found to be noninferior or superior to BTS placement with regards to primary outcomes, in addition to having a number of important other advantages over BTS placement. 12, 13 Attention to important procedural and periprocedural details are key to ensuring the success of PDA stenting, which are discussed in this article. 
| PREPROCEDURE PL ANNING

| INTERVENTIONAL PROCEDURE
The procedure is performed in the cardiac catheterization laboratory 
| Morphology and vascular access
Special attention is given to the morphology of the PDA, as this can influence techniques and help anticipate important outcomes (see below). We have proposed a morphological classification scheme for PDAs in infants with ductal-dependent PBF. 14 In the case of a ventricular septal defect, an antegrade femoral or umbilical venous approach may be used for PDAs that originate from the underside of the arch, however, negotiating multiple angles and curves in the PDA may still be cumbersome and add to the difficulty of the procedure. In addition, in small infants, there may be a risk of femoral arterial trauma/thrombosis when using four French delivery sheaths. 15 The umbilical vessels may mitigate the risk of vascular access complications if available for use. For PDAs that originate from the underside of the aortic arch (and some from the head/neck vessels), percutaneous axillary artery or common carotid artery access facilitates a direct and straight trajectory which allows for easier maneuverability of guidewires/stent systems. While previously axillary artery or common carotid artery access was performed via surgical cut down techniques, percutaneous axillary and percutaneous carotid artery access for PDA stenting has been shown to be safe and effective. [16] [17] [18] [19] We perform percutaneous axillary ( Figure 3 ) and percutaneous carotid artery ( Figure 4 ) access for these procedures with ultrasound guidance to ensure an isolated anterior wall puncture. In our multicenter experience, most PDAs from the underside of the aortic arch were accessed from a common carotid or axillary artery approach, while the femoral artery/femoral vein was the preferred access site for those PDAs originating from the descending aorta. Preliminary data on the use and pharmacokinetics in neonates using a single DES to stent the PDA have been reported. 22 These preliminary data suggest significantly lower clearance of sirolimus in neonates and peak sirolimus levels being 20 times higher than in older children and adults. Despite these findings, the authors did not note any adverse clinical outcomes due to the prolonged immunosuppressive sirolimus levels. We have used DES in neonates for ductal stenting and have noted significant benefits with regards to less luminal loss and decreased reintervention rates compared to bare metal stents, in retrospective analysis, without identification of adverse clinical outcomes due to systemic immunosuppression. 23 However, multi-institutional studies need to be performed to verify these benefits in larger cohorts of patients.
Once the stent is deployed, the PDA anatomy is reassessed with the wire still in place to ascertain whether placement of another stent is necessary. Restenting is much easier to accomplish over the same guidewire and can be difficult after guidewire withdrawal. Examination of distal pulses (if femoral or axillary arterial access is used) and ultrasound of the access site can be performed in the cardiac catheterization laboratory prior to patient transfer.
| Complications
In addition to other complications, adverse events specifically related to ductal stenting should be kept in mind. In our experience, the complication most frequently encountered (9%) is vascular-related injury. 12 Ductal dissection, though rare, 13 
| P OS TPRO CEDURE PREC AUTI ON S AND MONITORING
Patients are monitored in the hospital for at least 24 hours after the procedures with follow up chest radiographs and echocardiograms. We start patients on aspirin 3-5 mg/kg/day and heparin is 
| S PECIAL CONS IDER ATIONS
According to the 2011 AHA guidelines, 24 
| CON CLUS IONS
Techniques of ductal stenting for infants with ductal-dependent PBF have evolved rapidly over the last decade. Attention to anatomic and technical details optimizes the success of the procedure. The morphological classification scheme is helpful in anticipating acute and longterm outcomes of the procedure. It is likely that we will see further refinement of imaging, procedural techniques, and equipment used for PDA stenting in the ensuing years.
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